 |
PDA Chemistry Manufacturing & Controls (CMC) Workshop
May 14, 2012
Bethesda, Maryland
Global Clinical Trials Outsourcing Summit
May 14, 2012—May 15, 2012
Seoul, South Korea
Sixth International Pharmaceutical Compliance Congress
May 14, 2012—May 16, 2012
Budapest, Hungary
PDA FDA Virus and TSE Safety Conference
May 15, 2012—May 17, 2012
Bethesda, Maryland
Pharma Outsourcing & Procurement Summit 2012
May 21, 2012—May 22, 2012
Berlin, Germany
|
|
|
 |
 
Confirm your ePT Weekly subscription
We noticed you haven't opened your ePT Weekly in quite a while. While we don't want to lose you as a valuable reader, we understand that preferences change. If you would like to continue receiving ePT Weekly, please take a moment to confirm your subscription by clicking here.
If you have just been having trouble receiving your ePT Weekly, be sure to add our new email address [email protected] to your address book or safe sender list to ensure delivery.
Thank you,
Pharmaceutical Technology Staff
P.S. You can also use this form to subscribe to other informative e-newsletters from Pharmaceutical Technology – just click here to sign up today! |
|
| |
 |
 |
 Biosensor provides high-throughput capabilities
SAW Instruments’s samX acoustic biosensor is designed to provide enhanced workflow flexibility and a high-throughput capability for applications involving the analysis of molecular interactions on cellular surfaces. The device uses SAW’s proprietary surface acoustic wave technology to detect mass binding and protein-conformational changes on whole cells. The company’s range of sam acoustic biosensors also offers real-time analysis using viable cells while eliminating the need for molecular labeling.
The samX features two sensor chips, rather than the single chip in SAW's existing sam5 models, and incorporates eight analysis channels. The biosensor also contains advanced fluidic system and each channel can be used independently or via combinations of 4 x 2, 2 x 4, or 1 x 8 channels, offering a highly flexible workflow. In addition, different ligands can now be automatically immobilized on-line at each chip position via the fluidics, thus eliminating the need for off-line protein loading while providing more accurate and reliable results.
|
Advertisement:
More software vendors are providing solutions for Quality and Compliance Management than ever before. With a high demand and a large vendor landscape, it sometimes becomes difficult to discern which systems provide the greatest value and guarantee a successful implementation. Learn the best practices when selecting a software vendor, pitfalls to avoid, and business cases for each consideration  Read More. |
|
|
 |
|
Daiichi Sankyo and the biopharmaceutical company Coherus BioSciences have agreed to develop and commercialize biosimilar forms of etanercept and rituximab in several Asian countries, including Japan. Under the terms of the agreement, Daiichi Sankyo and Coherus BioSciences will work together to develop, manufacture, and commercialize biosimilar forms of etanercept and rituximab developed by Coherus BioSciences. Upon marketing approval, Daiichi Sankyo will commercialize these products in Japan, South Korea, and Taiwan. Coherus has retained all additional development and commercial rights outside of the licensed territories. Read More
Advertisement:
How-to Video Series: Tablet Press Setup
Get the most from your processing equipment by learning how to properly setup your tablet press. Natoli's newest "how-to" video series demonstrates the correct way to setup your tablet press with step-by-step tooling installation instructions. If you want to get the most from your tablet press and tooling, you can't afford to miss this must-see video series!
 http://www.natoli.com/Press-Setup/Press-Setup-Videos-PT2.html |
The China-based investment group of Johnson & Johnson (J&J) has acquired Guangzhou Bioseal Biotech, a privately held biopharmaceutical company specializing in the design, development, and commercialization of a porcine plasma-derived biologic product for controlling bleeding during surgery. The acquisition was completed after obtaining all necessary Chinese Government approvals. Guangzhou Bioseal Biotech manufactures a porcine-derived fibrin sealant, Bioseal, currently the only porcine plasma-derived fibrin sealant approved for use in China. Guangzhou Bioseal Biotech will work with Ethicon, a J&J subsidiary. Read More
Sandoz, a subsidiary of Novartis, has agreed to acquire specialty dermatology generic-drug company Fougera Pharmaceuticals for $1.525 billion. The acquisition is subject to customary closing conditions and regulatory approval. Read More
Advertisement:
For contract manufacturing of single-use drug delivery formats contact Tapemark. We specialize in active/passive transdermal patches, topical patches and pads, soluble film, and our patented Snap!® and Snapplicator™ packaging for unit-dose semisolids. Tapemark is cGMP-compliant, ISO 9001/13485 certified, FDA audited-Drug/Device/Food and DEA registered as a Schedule III – V Manufacturer of Controlled Substances. Tapemark has been successfully audited by the EU, Japan, Australia and Korea.  http://www.tapemark.com/pharm.html |
Industry Briefs:
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers. Read More
Advertisement:
Pharmaceutical Technology Presents Bio/Pharmaceutical Manufacturing Outsourcing
Build Strategic Partnerships • Improve Technology Transfer • Mitigate Risk
July 24-25, 2012 Philadelphia, PA
In this focused, interactive forum, bio/pharmaceutical executives come together with contract manufacturing organizations to discuss strategies for effective operations, quality oversight and risk mitigation. Join your colleagues to hear the latest regulatory trends, learn best sourcing practices and identify business opportunities in the outsourcing arena.
Register by June19th at  http://www.cbinet.com/outsourcing and save $300 with priority code: AMS592 |
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to [email protected] |
Advertisement:
CBI's Biopharmaceutical Forum on Clinical and Commercial Global Supply Chain Excellence
Ensure End-to-End Integrity and Adapt to Fit Regulatory, Market and Operational Needs
July 24-25, 2012 * New Brunswick, NJ * Hyatt Regency New Brunswick
This conference brings together the clinical and commercial supply teams for thought sharing on intersecting issues while still addressing unique challenges during tracked (clinical/commercial) sessions. Hear organizational strategies and learn how industry peers are managing the diverse supply chain network including cross functional-teams, suppliers, global/virtual teams etc.
Register by July 24th at  http://www.cbinet.com/supplychain and save $300 with priority code: HCJ494 |
| |
 |
| Meeting Manufacturing Challenges Tied to Extended-Release Injectables |
by: Angie Drakulich
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.
 |
Coming soon: Coming soon: Pharm Tech's June issue analyzes the market of monoclonal antibodies, recombinant proteins, and vaccines in contract biologics manufacturing. |
|
|
Advertisement:
Meeting New Method Transfer Requirements
Live Webcast: May 15, 2012 at 11:00 AM EDT for North America and May 22, 2012 at 11:00 AM CET for Europe
Register Free at  http://www.pharmtech.com/method |
|
|
Know Before You Go—2012 Conference Previews
Visit our Show & Exhibition Gateway 2012 to see which companies are exhibiting at upcoming industry conferences.
Find company backgrounders, new product releases, booth materials, and more. Let PharmTech's online
Gateway be your guide to the season's leading shows.
|
Advertisement:
When Softgels Are a Good First Option: Overcoming Bioavailability Challenges
Live Webcast: Tuesday, June 12, 2012 at 11:00 am ET
Register Free at  http://www.pharmtech.com/softgels |
|
|
|
|
|
|
